drugset / Trial / NCT00332462
A Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant Recipients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The aim of this exploratory study is to evaluate the rejection rate in patients treated with cyclosporine (CsA) preceding oral administration of cyclosporine micro emulsion in de novo liver recipients. The blood levels of CsA and CsA micro emulsion will be monitored by C-2h monitoring. In addition, this study will assess the safety of this treatment regimen.
Timeline
- Start
- 2006-05
- Primary completion
- 2008-04
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 8 mg/kg | Intravenous |
| Subject | Cyclosporine | Peptide | 12 mg/kg | Intravenous |
| Subject | Cyclosporine | Peptide | 200 mg | Intravenous |
Indications
No indication recorded.